Holly Maier

1.2k total citations
8 papers, 953 citations indexed

About

Holly Maier is a scholar working on Endocrine and Autonomic Systems, Pharmacology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Holly Maier has authored 8 papers receiving a total of 953 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Endocrine and Autonomic Systems, 3 papers in Pharmacology and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Holly Maier's work include Regulation of Appetite and Obesity (4 papers), Pharmacology and Obesity Treatment (3 papers) and Diabetes Treatment and Management (3 papers). Holly Maier is often cited by papers focused on Regulation of Appetite and Obesity (4 papers), Pharmacology and Obesity Treatment (3 papers) and Diabetes Treatment and Management (3 papers). Holly Maier collaborates with scholars based in United States. Holly Maier's co-authors include Christian Weyer, Éric Ravussin, Joy E. Koda, Julie A. Mitchell, Kevin Shan, Reshma Shringarpure, Steven R. Smith, Michael G. Perri, Dennis Dong Hwan Kim and Patrick M. O’Neil and has published in prestigious journals such as Diabetes Care, Endocrinology and American Journal of Physiology-Endocrinology and Metabolism.

In The Last Decade

Holly Maier

8 papers receiving 878 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Holly Maier United States	8	493	468	434	303	167	8	953
M. Fitchet United States	8	456 0.9×	343 0.7×	310 0.7×	112 0.4×	60 0.4×	8	773
Xiaosong Li China	7	195 0.4×	156 0.3×	257 0.6×	170 0.6×	144 0.9×	14	586
JE Morley Netherlands	6	98 0.2×	211 0.5×	163 0.4×	103 0.3×	51 0.3×	7	616
Enma Araujo de Baptista Venezuela	11	109 0.2×	281 0.6×	272 0.6×	62 0.2×	38 0.2×	11	651
V. Margaret Jackson United States	14	58 0.1×	104 0.2×	163 0.4×	154 0.5×	75 0.4×	24	507
Susan L.F. Chan United Kingdom	16	155 0.3×	121 0.3×	171 0.4×	42 0.1×	320 1.9×	30	1.0k
Marta Baranowska‐Kuczko Poland	14	348 0.7×	161 0.3×	61 0.1×	103 0.3×	57 0.3×	32	527
Martin Schnelle Germany	7	611 1.2×	61 0.1×	127 0.3×	44 0.1×	38 0.2×	8	818
Teresa Aveta Italy	10	251 0.5×	104 0.2×	97 0.2×	64 0.2×	40 0.2×	10	367
Chunli Lei China	6	54 0.1×	81 0.2×	151 0.3×	247 0.8×	79 0.5×	9	372

Countries citing papers authored by Holly Maier

Since Specialization

Citations

This map shows the geographic impact of Holly Maier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holly Maier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holly Maier more than expected).

Fields of papers citing papers by Holly Maier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Holly Maier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holly Maier. The network helps show where Holly Maier may publish in the future.

Co-authorship network of co-authors of Holly Maier

This figure shows the co-authorship network connecting the top 25 collaborators of Holly Maier. A scholar is included among the top collaborators of Holly Maier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Holly Maier. Holly Maier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Wadden, Thomas A., John P. Foreyt, Gary D. Foster, et al.. (2010). Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR‐BMOD Trial. Obesity. 19(1). 110–120. 398 indexed citations

2.

Roth, Jonathan D., Holly Maier, Steve Chen, & Barbara Roland. (2009). Implications of Amylin Receptor Agonism. Archives of Neurology. 66(3). 306–10. 46 indexed citations

3.

Ravussin, Éric, Steven R. Smith, Julie A. Mitchell, et al.. (2009). Enhanced Weight Loss With Pramlintide/Metreleptin: An Integrated Neurohormonal Approach to Obesity Pharmacotherapy. Obesity. 17(9). 1736–1743. 259 indexed citations

4.

Edelman, Steve, Holly Maier, & Ken Wilhelm. (2008). Pramlintide in the Treatment of Diabetes Mellitus. BioDrugs. 22(6). 375–386. 48 indexed citations

5.

Roth, Jonathan D., Heather Hughes, Todd Coffey, et al.. (2007). Effects of prior or concurrent food restriction on amylin-induced changes in body weight and body composition in high-fat-fed female rats. American Journal of Physiology-Endocrinology and Metabolism. 293(4). E1112–E1117. 25 indexed citations

6.

Wysham, Carol, Cameron W. Lush, Bei Zhang, Holly Maier, & Ken Wilhelm. (2007). Effect of pramlintide as an adjunct to basal insulin on markers of cardiovascular risk in patients with type 2 diabetes. Current Medical Research and Opinion. 24(1). 79–85. 24 indexed citations

7.

Riddle, Matthew C., Juan P. Frías, Bei Zhang, et al.. (2007). Pramlintide Improved Glycemic Control and Reduced Weight in Patients With Type 2 Diabetes Using Basal Insulin. Diabetes Care. 30(11). 2794–2799. 89 indexed citations

8.

Roth, Jonathan D., Todd Coffey, Carolyn M. Jodka, et al.. (2007). Combination Therapy with Amylin and Peptide YY[3–36] in Obese Rodents: Anorexigenic Synergy and Weight Loss Additivity. Endocrinology. 148(12). 6054–6061. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact